Position in NTRA
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$374,329
-$99,727 QoQ
Shares Held
1,379
-53.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#584
of 844 holders
Holding Since
Jun 2023
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CAPSTONE INVESTMENT ADVISORS, LLC holds $2,327,741 across 6 Diagnostics & Research names. NTRA ranks #3 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
2,836 | $601,090 | |
| 2 | A |
Agilent Technologies, Inc.
|
4,453 | $591,491 | |
| 3 | NTRA |
Natera, Inc.
This page
|
1,379 | $374,329 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
229 | $292,549 | |
| 5 | GH |
Guardant Health, Inc.
|
1,691 | $253,700 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
428 | $214,582 |
All Filings in NTRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $374,329 | 1,379 | Shares | Defined | 2026-08-17 | |
| 2025-09-30 | $474,056 | 2,945 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $351,057 | 2,078 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $367,414 | 2,321 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $446,356 | 3,516 | Shares | Sole | 2024-11-14 | |
| 2023-06-30 | $263,883 | 5,423 | Shares | Sole | 2023-08-10 | |
| No filing history on record for this holder in this stock. | ||||||